UPPSALA, Sweden, April 02, 2024 (GLOBE NEWSWIRE) Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of an open access data library consisting of over 300,000 protein-disease risk associations, giving researchers a powerful new tool for revealing the biological mechanisms underlying 106 human diseases. In April 2023, the UK Biobank Pharma Proteomics Project (UKB-PPP) released data produced from over 50,000 samples analyzed using the Olink® Explore platform. The UKB-PPP is t
Innovation and transparency at the heart of Olink’s culture – details of the technology behind the Olink Explore high-throughput proteomics platform published in the journal, Molecular & Cellular ProteomicsUPPSALA,Sweden, Dec. 06, 2021 (GLOBE NEWSWIRE) Olink Holding AB (publ) (Nasdaq: OLK) today a.